CLINICAL DEVELOPMENT OF BIOLOGICS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION, 2003-2016

被引：0
|
作者：
Alexander, G. C. [1 ]
Ogasawara, K. [1 ]
Wiegand, D. [1 ]
Lin, D. H. [2 ]
Breder, C. D. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1237
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP343
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [21] Strong Pharmacokinetic Drug-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2021: Mechanisms and Clinical Implications
    Yu, Jingjing
    Wang, Yan
    Ragueneau-Majlessi, Isabelle
    CLINICAL THERAPEUTICS, 2022, 44 (11) : 1536 - 1544
  • [22] Characteristics of Trials Associated With Drugs Approved by the Food and Drug Administration in 2015 and 2016
    Eckert, Joy C.
    MEDICAL CARE, 2020, 58 (03) : 194 - 198
  • [23] Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis
    Wallach, Joshua D.
    Egilman, Alexander C.
    Dhruva, Sanket S.
    McCarthy, Margaret E.
    Miller, Jennifer E.
    Woloshin, Steven
    Schwartz, Lisa M.
    Ross, Joseph S.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [24] Estratest is not approved by the Food and Drug Administration
    Suthers, Kristen
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (02) : 205 - 206
  • [25] Food and drug administration chief approved
    不详
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) : 57 - 58
  • [26] Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
    Skydel, Joshua J.
    Luxkaranayagam, Anita T.
    Dhruva, Sanket S.
    Ross, Joseph S.
    Wallach, Joshua D.
    JAMA NETWORK OPEN, 2019, 2 (05)
  • [27] Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016
    Moore, Thomas J.
    Zhang, Hanzhe
    Anderson, Gerard
    Alexander, G. Caleb
    JAMA INTERNAL MEDICINE, 2018, 178 (11) : 1451 - 1457
  • [28] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (08) : 867 - 885
  • [29] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020
    Gizem Kayki-Mutlu
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 839 - 852
  • [30] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2949 - 2970
12345